BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6334898)

  • 1. [Intrathymic differentiation of the T lymphocyte and classification of the T-cell lymphoproliferative disorders].
    García Rodríguez MC
    Sangre (Barc); 1984; 29(4-C):696-701. PubMed ID: 6334898
    [No Abstract]   [Full Text] [Related]  

  • 2. [Functional activity of thymic subpopulations].
    Gómez de la Concha E; Campos A; Subiza JL; Zabay JM
    Sangre (Barc); 1984; 29(4-C):724-30. PubMed ID: 6240121
    [No Abstract]   [Full Text] [Related]  

  • 3. [Spectrum of lymphoproliferative diseases].
    Franssila K
    Duodecim; 1989; 105(11):1016-39. PubMed ID: 2666087
    [No Abstract]   [Full Text] [Related]  

  • 4. T-lymphocyte malignancies: recent advances in the understanding of their biology, diagnosis and treatment.
    Parkinson DR; Mier JW
    Clin Immunol Rev; 1983; 2(1):59-121. PubMed ID: 6349892
    [No Abstract]   [Full Text] [Related]  

  • 5. The chronic proliferative disease of large granular lymphocytes.
    Bassan R; Rambaldi A; Barbui T
    Haematologica; 1989; 74(1):85-94. PubMed ID: 2498190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical manifestations of lymphoproliferative disorders of thymic origin].
    Pintado Cros T
    Sangre (Barc); 1984; 29(4-C):731-40. PubMed ID: 6240122
    [No Abstract]   [Full Text] [Related]  

  • 7. Proposed categorization of pathological states of EBV-associated T/natural killer-cell lymphoproliferative disorder (LPD) in children and young adults: overlap with chronic active EBV infection and infantile fulminant EBV T-LPD.
    Ohshima K; Kimura H; Yoshino T; Kim CW; Ko YH; Lee SS; Peh SC; Chan JK;
    Pathol Int; 2008 Apr; 58(4):209-17. PubMed ID: 18324913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary cutaneous lymphoproliferative disorders with dual lineage rearrangement.
    Kazakov DV; Kutzner H; Palmedo G; Boudova L; Michaelis S; Michal M; Vanecek T; Magro CM; Mukensnabl P; Dummer R; Burg G; Kempf W
    Am J Dermatopathol; 2006 Oct; 28(5):399-409. PubMed ID: 17012914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biologic and clinical heterogeneity of lymphoproliferative diseases of peripheral mature T lymphocytes.
    Pandolfi F; Zambello R; Cafaro A; Semenzato G
    Lab Invest; 1992 Sep; 67(3):274-302. PubMed ID: 1405488
    [No Abstract]   [Full Text] [Related]  

  • 10. Cell cycle regulation by FasL and Apo2L/TRAIL in human T-cell blasts. Implications for autoimmune lymphoproliferative syndromes.
    Bosque A; Aguiló JI; del Rey M; Paz-Artal E; Allende LM; Naval J; Anel A
    J Leukoc Biol; 2008 Aug; 84(2):488-98. PubMed ID: 18483205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic treatment of C3H-lpr/lpr and C3H-gld/gld mice with anti-CD8 monoclonal antibody prevents the accumulation of double negative T cells but not autoantibody production.
    Giese T; Davidson WF
    J Immunol; 1994 Feb; 152(4):2000-10. PubMed ID: 8120404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a functional T-cell population by the use of surface markers: present limitations and new strategies.
    Mingari MC; Moretta A; Pantaleo G; Moretta L
    Ann Immunol (Paris); 1982; 133D(2):147-53. PubMed ID: 6819808
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinicopathological states of Epstein-Barr virus-associated T/NK-cell lymphoproliferative disorders (severe chronic active EBV infection) of children and young adults.
    Suzuki K; Ohshima K; Karube K; Suzumiya J; Ohga S; Ishihara S; Tamura K; Kikuchi M
    Int J Oncol; 2004 May; 24(5):1165-74. PubMed ID: 15067338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new form of T-cell PTLD.
    Litz C; Hanson M
    Am J Clin Pathol; 2000 Apr; 113(4):598. PubMed ID: 10761467
    [No Abstract]   [Full Text] [Related]  

  • 15. Delineation of human thymocyte differentiation pathways utilizing double-staining techniques with monoclonal antibodies.
    Tidman N; Janossy G; Bodger M; Granger S; Kung PC; Goldstein G
    Clin Exp Immunol; 1981 Sep; 45(3):457-67. PubMed ID: 6461444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Heterogeneity of T gamma-lymphoproliferative disorder-- case report and review of the literature].
    Hara J; Kawa-ha K; Doi S; Yumura K; Ishihara S; Kurahashi H; Yabuuchi H
    Rinsho Ketsueki; 1986 Dec; 27(12):2325-32. PubMed ID: 3553644
    [No Abstract]   [Full Text] [Related]  

  • 17. [Analyses of the rearrangement of T-cell receptor- and immunoglobulin genes in the diagnosis of lymphoproliferative disorders].
    Griesser DH
    Veroff Pathol; 1995; 144():1-109. PubMed ID: 7856305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunologic cell markers in lymphoproliferative diseases].
    Samoĭlova RS
    Ter Arkh; 1980; 52(9):140-9. PubMed ID: 7001662
    [No Abstract]   [Full Text] [Related]  

  • 19. The common gamma-chain of cytokine receptors regulates intrathymic T cell development at multiple stages.
    He YW; Nakajima H; Leonard WJ; Adkins B; Malek TR
    J Immunol; 1997 Mar; 158(6):2592-9. PubMed ID: 9058791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of human B cell tumor growth in SCID mice by monoclonal anti-B cell antibodies.
    Durandy A; Brousse N; Rozenberg F; De Saint Basile G; Fischer AM; Fischer A
    Immunodeficiency; 1993; 4(1-4):73-6. PubMed ID: 8167739
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.